Skip to main content

NOC Q3 Deep Dive: Backlog Growth and New Technologies Drive Outlook

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NOC Cover Image

Security and aerospace company Northrop Grumman (NYSE: NOC) met Wall Street’s revenue expectations in Q3 2026, with sales up 6.7% year on year to $11.12 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $44 billion at the midpoint. Its non-GAAP profit of $7.89 per share was 9.9% above analysts’ consensus estimates.

Is now the time to buy NOC? Find out in our full research report (it’s free for active Edge members).

Northrop Grumman (NOC) Q3 2026 Highlights:

  • Revenue: $11.12 billion vs analyst estimates of $11.15 billion (6.7% year-on-year growth, in line)
  • Adjusted EPS: $7.89 vs analyst estimates of $7.18 (9.9% beat)
  • The company reconfirmed its revenue guidance for the full year of $44 billion at the midpoint
  • Management raised its full-year Adjusted EPS guidance to $29.55 at the midpoint, a 2.4% increase
  • Operating Margin: 11.4%, in line with the same quarter last year
  • Backlog: $109.6 billion at quarter end, up 19.8% year on year
  • Market Capitalization: $75.86 billion

StockStory’s Take

Northrop Grumman’s third quarter was marked by strong execution across its key programs, as evidenced by a significant increase in its order backlog and robust operating performance. Management highlighted successful program progress in both aeronautics and defense systems, driven by higher production volumes on major contracts like the F-35 and the continued ramp-up of the B-21 Raider. CEO Kathy Warden specifically pointed to “record backlog” and disciplined program execution, noting the company’s ability to deliver on commitments and meet evolving customer needs in a dynamic threat environment.

Looking ahead, Northrop Grumman’s leadership emphasized that future growth will be underpinned by accelerating production on franchise programs such as Sentinel and B-21, as well as new product developments in microelectronics and autonomous systems. Management cited the company’s growing international opportunities and the potential to extend advanced technology into commercial markets. Warden stated, “We are investing to rapidly expand our munitions and missile capacity to meet operational needs and increased demand,” while also signaling that the company is evaluating strategic alternatives to scale its microelectronics business for both defense and commercial applications.

Key Insights from Management’s Remarks

Management attributed Q3 performance to strong demand for its major platforms, growing international interest, and new technology introductions, while emphasizing progress on strategic production ramps and portfolio investments.

  • Backlog expansion: Northrop Grumman’s backlog grew by nearly 20%, reflecting a book-to-bill ratio of 1.5x and strong demand across defense, space, and missile programs. Management cited new awards, including restricted programs and submarine contracts, as key contributors.
  • Aeronautics and defense volume growth: The Aeronautics segment delivered double-digit sales growth due to higher F-35 and B-21 production and sustainment activity. Defense Systems also saw a 12% increase in sales, supported by the ongoing Sentinel program ramp and tactical solid rocket motor production.
  • New product innovation: Management introduced the “Fortitude” microelectronics chip, which offers greater power and signal quality than current alternatives. In addition, Talon Blue, an autonomous aircraft platform, completed its first self-directed flight, showcasing rapid development and modular design capabilities.
  • Manufacturing investments: The company expanded manufacturing and engineering capacity—adding over one million square feet and 2,000 new jobs—to support accelerated production in key areas such as the B-21 Raider, hypersonic propulsion, and advanced space systems.
  • Portfolio shaping and international growth: The company is responding to rising allied defense budgets by tailoring offerings for international customers, including munitions, missile defense, and sensors, with the goal to double international sales by 2031. Management also highlighted the strategic review of its microelectronics business for broader commercial applications.

Drivers of Future Performance

Northrop Grumman’s outlook centers on the scaling of large franchise programs, new product commercialization, and margin expansion, with international demand and defense budgets serving as critical themes.

  • Production ramps and franchise programs: Management expects continued sales acceleration from programs like B-21 and Sentinel, as well as a ramp-up in solid rocket motor and munitions manufacturing. These are projected to drive above-company-average growth rates in coming years, with backlog providing visibility through 2028.
  • Portfolio diversification and technology commercialization: The company is pursuing both defense and commercial market opportunities for its microelectronics and quantum computing capabilities. Strategic alternatives for scaling these technologies—including potential partnerships or separations—are under review, with management optimistic about their growth potential.
  • Margin expansion and risk management: As development contracts shift toward higher-margin production contracts, management anticipates less earnings volatility and stronger overall profitability. However, they noted that risks include the timing of government appropriations, international contract awards, and the pace of new program ramp-ups.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be watching (1) the pace at which Northrop Grumman converts its substantial backlog into revenue through production ramps on B-21, Sentinel, and new missile systems, (2) progress on the commercialization and strategic alternatives for its microelectronics and quantum technologies, and (3) the rate of international order growth and execution on new contract awards. Monitoring margin trends as development programs transition to production will also be a key signpost for long-term profitability.

Northrop Grumman currently trades at $533.49, up from $510.65 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  260.10
-2.53 (-0.96%)
AAPL  340.06
+0.56 (0.16%)
AMD  540.34
+5.60 (1.05%)
BAC  50.86
+0.22 (0.43%)
GOOG  328.59
-7.81 (-2.32%)
META  710.16
+15.91 (2.29%)
MSFT  530.63
-1.24 (-0.23%)
NVDA  219.90
+3.43 (1.58%)
ORCL  128.56
-2.58 (-1.96%)
TSLA  387.90
+14.19 (3.80%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.